Ovid Therapeutics Inc.
USE OF GABOXADOL IN THE TREATMENT OF GASTROINTESTINAL TRACT DISORDERS AND ASTHMA

Abstract:

Treatment of irritable bowel syndrome, Crohn's disease, celiac disease, ulcerative colitis, microscopic colitis, and asthma using gaboxadol or a pharmaceutically acceptable salt thereof is provided. Also provided are therapeutic compositions that may be used to improve one or more symptoms of irritable bowel syndrome, Crohn's disease, celiac disease, ulcerative colitis, microscopic colitis, or asthma.